ClinicalTrials.gg
Status unknownNCT03032276SMPNSUpdated Feb 11, 2022

Safe Motherhood Promotion and Newborn Survival

An interventional study of Safe motherhood and newborn health promotion package in Neonatal Death and Maternal Death, sponsored by International Centre for Diarrhoeal Disease Research, Bangladesh. Status unknown. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2022-02-11.

Sponsored by International Centre for Diarrhoeal Disease Research, Bangladesh · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50,400
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

Primary objective of the study is to measure the impact of a comprehensive package of interventions introduced by the Safe Motherhood Promotion and Newborn Survival project on neonatal mortality in three Upazila of Chandpur district, Bangladesh

Read the detailed description

Burden: Globally around 6.3 million children under five years of age died in 2013, two third of which occur in the low \& middle income countries. Bangladesh is one of the LMICs countries with high burden of maternal and neonatal mortalities. In Bangladesh, there has been a considerable progress in reduction of both child and maternal mortality in recent decades. From 1994 to 2014 under-5 mortality rate has reduced from 133 to 46 per 1000 live births in Bangladesh; however, within the same timeframe neonatal mortality declined from 52 to 28 per 1000 live births. This slow decrease in newborn deaths means that it now constitutes a greater share of total under-5 deaths. At present, neonatal mortality accounts for 74% of deaths in infants and 61% in children aged less than 5 years. Similarly, the country was able to decline MMR by 70% between 1990 and 2013, from 574 to 170 per 100,000 live births, with an annual reduction rate of 5.0%. Such statistics highlights the importance of focusing on perinatal and early postnatal periods to prevent maternal and neonatal mortalities.

Knowledge gap: Safe motherhood promotion project (SMPP) was a five (5 yr) year pilot project, launched in July 2006, by the Government of Bangladesh (GOB) in collaboration with JICA. The aim of the project was to improve the health status of pregnant and postpartum women and neonates. SMPP implemented three linked activities i.e., advocacy at the central level, strengthening of health facilities and empowerment of community. Evaluation of SMPP found positive changes in UN process indicators on EmOC including met needs (up from 31% to 55%), case fatality rate (\<0.1%) and skilled birth attendance rate (from 18% to 25%). The major weakness of the previous assessment of SMPP were use of a before-after design without any concurrent comparison area and the assessment lacked population based mortality estimates, only measured hospital case fatality rate. Hence, there is lack of strong evidences regarding the impact of the project.

Relevance: The proposed project is expected to provide essential evidences to the GOB and other development partners with the help of stronger design and valid evaluation processes. It would help not only in prioritizing, planning, and further scaling-up of SMPNS interventions in other areas of Bangladesh but in informing other developing countries in similar settings also.

Hypothesis: Safe Motherhood and Newborn Survival intervention package will reduce neonatal mortality by 25%, in comparison to the routine services in Chandpur district, Bangladesh

Methods: A community-based, cluster-randomized design will be used to evaluate the effectiveness of an integrated "Safe Motherhood and Newborn Health Promotion Package" in Chandpur district, Bangladesh. Both quantitative and qualitative approaches will be employed to address the primary and secondary objectives. Baseline, midterm and end of intervention household survey will be conducted using validated structured questionnaire to assess the coverage of maternal \& newborn health interventions. Health facility assessments surveys will be conducted periodically to assess facility readiness and utilization of maternal and neonatal health services in the participating health facilities. Additionally, relevant data from routine Health Management Information System (HMIS) will be regularly collected and extracted An ongoing investigating system will be in place at the health facilities to identify and document maternal near miss cases.

Qualitative data will be collected for process documentation and in depth exploration of implementation challenges and contextual factors. Social capitals will be measured both quantitatively and qualitatively to assess the non health impact of the interventions. Qualitative data collection methods will include stakeholders' meeting, focus group discussions (FGD), periodic in-depth assessments, social mapping and other participatory exercises.

Outcome measures/variables: The primary outcome measure for evaluation of SMPNS intervention is reduction of neonatal mortality. In addition, changes in coverage and utilization of maternal \& newborn health services, cost effectiveness of implementation of intervention will also be measured.

02

Conditions studied

  • Neonatal Death
  • Maternal Death

Keywords

  • Safe motherhood
  • Newborn survival
  • Community
  • Cluster Randomized Trial
03

In context

Perinatal Death

120 studies on the registry are indexed under Perinatal Death; 25 are open to participants now.

This study's planned enrollment of 50,400 is above the median of 427 across 84 interventional studies indexed under Perinatal Death.

Browse Perinatal Death studies →

Lead sponsor

International Centre for Diarrhoeal Disease Research, Bangladesh is the lead sponsor of 206 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women with birth outcome in last three years

Exclusion criteria

Exclusion Criteria:

  • Unusual unions as per the contextual factors (demographics, terrain, functionality of health services, etc.) will be excluded.
  • If a union has a total population of less than 12,000 (the minimum required to get adequate sample of neonates) they will either be excluded
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50,400 participants (estimated)

Study arms

  • Experimental
    Intervention

    "'Safe motherhood and newborn health promotion package'" will be implemented in the intervention arm which comprise 15 randomly selected unions (lowest level of administrative unit).

    Other: Safe motherhood and newborn health promotion package

  • No intervention
    Comparison

    Another 15 union will be selected where no intervention will be implemented

Interventions

  • OtherSafe motherhood and newborn health promotion package

    The intervention package consists of three components: facility, community and linkages between the community and health facilities. Facility based interventions will serve both the comparison and intervention arms. However, other two interventions will serve the intervention arm only. Specific interventions and approaches for the three components will be implemented within the MOH\&FW service delivery system to improve MNH practices in families and communities and to increase the use of MNH services from appropriate facilities/providers. The intervention package has been developed based on the experiences from SMPP in Narsingdi district and on the basis of consultations with the International Advisory Body (IAB) that included GoB, JICA, ICDDR,B, other experts and stakeholders.

06

What researchers measure

Primary outcomes

  1. Reduction of neonatal mortality rate (NMR)

    NMR will be assessed at the beginning of the project. after that it will also assessed by two midline assessment after starting the intervention and finally it will be assessed during the endline survey

    Time frame: During baseline at year 1, in two mid-line at year 2 & 3 and finally after completion of the of the intervention at year 4

Secondary outcomes

  1. Changes in coverage and utilization of maternal and newborn health services

    This will be assessed to evaluate the effect of the comprehensive package of interventions on health and care seeking behavior for neonates and women during antepartum, intrapartum and postpartum period at baseline and end line survey on total population and during two mid line surveys in a sub set of population

    Time frame: At year 1 (baseline), year 2 and 3 (mid lines) and year 4 (end line)

  2. Cost effectiveness of implementing the interventions

    Costs for improved neonatal health outcomes and related health services. This will be assessed by analyzing Costs per DALY averted, Costs per life-year gained; Costs per case of delivery by skilled attendance; Costs per case of essential neonatal care, Program cost, both start up and post implementation, Incremental health service costs for providing quality services, Out of pocket expenditure etc.

    Time frame: Every six months for programme costs

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18. PubMed 25530442 ↗
  • Caulfield LE, de Onis M, Blossner M, Black RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr. 2004 Jul;80(1):193-8. doi: 10.1093/ajcn/80.1.193. PubMed 15213048 ↗
  • Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS; Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet. 2003 Jul 5;362(9377):65-71. doi: 10.1016/S0140-6736(03)13811-1. PubMed 12853204 ↗
  • Victora CG, Wagstaff A, Schellenberg JA, Gwatkin D, Claeson M, Habicht JP. Applying an equity lens to child health and mortality: more of the same is not enough. Lancet. 2003 Jul 19;362(9379):233-41. doi: 10.1016/S0140-6736(03)13917-7. PubMed 12885488 ↗
  • Lawn JE, Cousens S, Zupan J; Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: when? Where? Why? Lancet. 2005 Mar 5-11;365(9462):891-900. doi: 10.1016/S0140-6736(05)71048-5. PubMed 15752534 ↗
  • Terra de Souza AC, Peterson KE, Andrade FM, Gardner J, Ascherio A. Circumstances of post-neonatal deaths in Ceara, Northeast Brazil: mothers' health care-seeking behaviors during their infants' fatal illness. Soc Sci Med. 2000 Dec;51(11):1675-93. doi: 10.1016/s0277-9536(00)00100-3. PubMed 11072887 ↗
  • Baqui AH, Arifeen SE, Williams EK, Ahmed S, Mannan I, Rahman SM, Begum N, Seraji HR, Winch PJ, Santosham M, Black RE, Darmstadt GL. Effectiveness of home-based management of newborn infections by community health workers in rural Bangladesh. Pediatr Infect Dis J. 2009 Apr;28(4):304-10. doi: 10.1097/INF.0b013e31819069e8. PubMed 19289979 ↗
  • Wakefield SE, Poland B. Family, friend or foe? Critical reflections on the relevance and role of social capital in health promotion and community development. Soc Sci Med. 2005 Jun;60(12):2819-32. doi: 10.1016/j.socscimed.2004.11.012. Epub 2004 Dec 24. PubMed 15820589 ↗
  • Hawe P, Shiell A. Social capital and health promotion: a review. Soc Sci Med. 2000 Sep;51(6):871-85. doi: 10.1016/s0277-9536(00)00067-8. PubMed 10972431 ↗
  • Pagel C, Prost A, Lewycka S, Das S, Colbourn T, Mahapatra R, Azad K, Costello A, Osrin D. Intracluster correlation coefficients and coefficients of variation for perinatal outcomes from five cluster-randomised controlled trials in low and middle-income countries: results and methodological implications. Trials. 2011 Jun 14;12:151. doi: 10.1186/1745-6215-12-151. PubMed 21672223 ↗
  • De Silva MJ, Harpham T, Tuan T, Bartolini R, Penny ME, Huttly SR. Psychometric and cognitive validation of a social capital measurement tool in Peru and Vietnam. Soc Sci Med. 2006 Feb;62(4):941-53. doi: 10.1016/j.socscimed.2005.06.050. Epub 2005 Aug 10. PubMed 16095787 ↗
  • Bland JM, Altman DG. Cronbach's alpha. BMJ. 1997 Feb 22;314(7080):572. doi: 10.1136/bmj.314.7080.572. No abstract available. PubMed 9055718 ↗
  • El Arifeen S, Hill K, Ahsan KZ, Jamil K, Nahar Q, Streatfield PK. Maternal mortality in Bangladesh: a Countdown to 2015 country case study. Lancet. 2014 Oct 11;384(9951):1366-74. doi: 10.1016/S0140-6736(14)60955-7. Epub 2014 Jun 29. PubMed 24990814 ↗
  • Hoque DME, Chowdhury MAK, Rahman AE, Billah SM, Bari S, Tahsina T, Hasan MM, Islam S, Islam T, Mori R, Arifeen SE. A community-based cluster randomized controlled trial (cRCT) to evaluate the impact and operational assessment of "safe motherhood and newborn health promotion package": study protocol. BMC Public Health. 2018 May 3;18(1):592. doi: 10.1186/s12889-018-5478-6. PubMed 29724194 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03032276
Collaborators
Government of Bangladesh, Tokyo University
Responsible party
Sponsor
First posted
Jan 26, 2017
Start date
Jul 2016
Primary completion
Jul 2022 (estimated)
Completion
Jul 2022 (estimated)
Last update
Feb 11, 2022

Study contacts

Shams El Arifeen, DrPH, MBBS
principal investigator · International Centre for Diarrhoeal Disease Research, Bangladesh
D M Emdadul Hoque, MPH, MBBS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Sanwarul Bari, MBBS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Masum Billah, MPH, BURP
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Ahmed Ehsanur Rahman, MPH, MBBS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Tazeen Tahsina, MS Economics
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Mohiuddin Ahsanul Kabir Chowdhury, MPH, MBBS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Mohammad Mehedi Hasan, MPH, MSc
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Sajia Islam, MPH, BDS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Mohammad Masudur Rahman, MPS, MBBS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Nazia Binte Ali, MPH, MBBS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh
Jasmin Khan, MPH, MSS
study director · International Centre for Diarrhoeal Disease Research, Bangladesh

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion